Diabetic nephropathy: Lessons from the mouse

Ochsner Journal

Volumn 13, Issue 1, 2013, Pages 140-146

  Vashistha, Himanshu ^a   Meggs, Leonard ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Diabetic nephropathies; Oxidative stress; P66Shc protein; Proteinuria

Indexed keywords

PROTEIN P66; REACTIVE OXYGEN METABOLITE; SIRTUIN 1;

ACETYLATION; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE DELETION; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; KIDNEY TUBULE DAMAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; P66 GENE; PHENOTYPE; PODOCYTE;

EID: 84875165676     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mitch WE. Treating diabetic nephropathy-are there only economic issues. N Engl J Med. 2004 Nov 4;351(19):1934-1936. Epub 2004 Oct 31.
2. Brenner BM. Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest. 2002 Dec;110(12): 1753-1758.
3. Huang W, Gallois Y, Bouby N, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A. 2001 Nov 6; 98(23):13330-13334. Epub 2001 Oct 30.
4. Kakoki M, Takahashi N, Jennette JC, Smithies O. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36): 13302-13305. Epub 2004 Aug 23.
5. Kakoki M, Kizer CM, Yi X, et al. Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest. 2006 May;116(5):1302-1309. Epub 2006 Apr 6.
6. Kakoki M, McGarrah RW, Kim HS, Smithies O. Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7576-7581. Epub 2007 Apr 23.
7. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005 Jun;54(6):1615-1625.
8. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen speciesregulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S241-S245.
9. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S221-S226.
10. Deltour L, Vandamme J, Jouvenot Y, et al. Differential expression and imprinting status of Ins1 and Ins2 genes in extraembryonic tissues of laboratory mice. Gene Expr Patterns. 2004 Dec;5(2):297-300.
11. Kang BP, Urbonas A, Baddoo A, Baskin S, Malhotra A, Meggs LG. IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol. 2003 Nov;285(5):F1013-F1024. Epub 2003 Jul 22.
12. Yang S, Chintapalli J, Sodagum L, et al. Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol. 2005 Nov;289(5):F1144-F1152. Epub 2005 Jun 14.
13. Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999 Nov 18;402(6759):309-313.
14. Zhou S, Chen HZ, Wan YZ, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011 Sep 2;109(6):639-648. Epub 2011 Jul 21.